Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Institute of Radiooncology - OncoRay Helmholtz-Zentrum Dresden - Rossendorf, Dresden, Germany.
Br J Radiol. 2020 Mar;93(1107):20190879. doi: 10.1259/bjr.20190879. Epub 2019 Dec 20.
Locally recurrent disease is of increasing concern in (non-)small cell lung cancer [(N)SCLC] patients. Local reirradiation with photons or particles may be of benefit to these patients. In this multicentre in trial performed within the Radiation Oncology Collaborative Comparison (ROCOCO) consortium, the doses to the target volumes and organs at risk (OARs) were compared when using several photon and proton techniques in patients with recurrent localised lung cancer scheduled to undergo reirradiation.
24 consecutive patients with a second primary (N)SCLC or recurrent disease after curative-intent, standard fractionated radio(chemo)therapy were included in this study. The target volumes and OARs were centrally contoured and distributed to the participating ROCOCO sites. Remaining doses to the OARs were calculated on an individual patient's basis. Treatment planning was performed by the participating site using the clinical treatment planning system and associated beam characteristics.
Treatment plans for all modalities (five photon and two proton plans per patient) were available for 22 patients ( = 154 plans). 3D-conformal photon therapy and double-scattered proton therapy delivered significantly lower doses to the target volumes. The highly conformal techniques, ., intensity modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT), CyberKnife, TomoTherapy and intensity-modulated proton therapy (IMPT), reached the highest doses in the target volumes. Of these, IMPT was able to statistically significantly decrease the radiation doses to the OARs.
Highly conformal photon and proton beam techniques enable high-dose reirradiation of the target volume. They, however, significantly differ in the dose deposited in the OARs. The therapeutic options, ., reirradiation or systemic therapy, need to be carefully weighed and discussed with the patients.
Highly conformal photon and proton beam techniques enable high-dose reirradiation of the target volume. In light of the abilities of the various highly conformal techniques to spare specific OARs, the therapeutic options need to be carefully weighed and patients included in the decision-making process.
局部复发性疾病是(非)小细胞肺癌[(N)SCLC]患者日益关注的问题。对于这些患者,用光子或粒子进行局部再照射可能有益。在辐射肿瘤学协作比较(ROCOCO)联盟内进行的这项多中心试验中,比较了局部复发性肺癌患者再照射时使用几种光子和质子技术时靶体积和危及器官(OAR)的剂量。
本研究纳入了 24 例接受根治性标准分割放化疗后出现第二原发(N)SCLC 或局部复发的患者。靶体积和 OAR 由中心勾画并分发给参与 ROCOCO 的站点。根据每位患者的情况计算剩余的 OAR 剂量。治疗计划由参与站点使用临床治疗计划系统和相关束特性完成。
所有模式(每位患者 5 个光子和 2 个质子计划)的治疗计划均可用于 22 例患者(=154 个计划)。3D 适形光子治疗和双散射质子治疗可显著降低靶体积的剂量。高度适形技术,...,调强放疗(IMRT)、容积调强弧形治疗(VMAT)、CyberKnife、TomoTherapy 和调强质子治疗(IMPT),可在靶体积中达到最高剂量。其中,IMPT 能够在统计学上显著降低 OAR 的辐射剂量。
高度适形光子和质子束技术可实现靶体积的高剂量再照射。然而,它们在 OAR 中沉积的剂量有显著差异。需要仔细权衡再照射或系统治疗等治疗选择,并与患者进行讨论。
高度适形光子和质子束技术可实现靶体积的高剂量再照射。鉴于各种高度适形技术在保护特定 OAR 方面的能力,需要仔细权衡治疗选择,并让患者参与决策过程。